Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice

Ocular herpes simplex virus type-1 (HSV-1) infections remain an important cause of corneal disease which may result in a loss of vision. Meliacine (MA), an antiviral activity present in crude leaf extracts of Melia azedarach L. that inhibits HSV-1 multiplication in vitro, was studied in a murine her...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pifarré, María Paula, Coto, Celia Esther, Alche, Laura Edith
Publicado: 2002
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00144835_v75_n3_p327_PaulaPifarre
http://hdl.handle.net/20.500.12110/paper_00144835_v75_n3_p327_PaulaPifarre
Aporte de:
id paper:paper_00144835_v75_n3_p327_PaulaPifarre
record_format dspace
spelling paper:paper_00144835_v75_n3_p327_PaulaPifarre2023-06-08T14:37:19Z Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice Pifarré, María Paula Coto, Celia Esther Alche, Laura Edith Herpes simplex virus In vivo Latency Melia azedarach L. Murine model Plant antiviral Stromal keratitis Melia azedarach extract meliacine plant extract unclassified drug animal cell animal experiment animal model animal tissue antiviral activity article controlled study disease severity Herpes simplex virus 1 histopathology immunomodulation inoculation keratitis microscopy mouse necrosis nonhuman priority journal vascularization Ocular herpes simplex virus type-1 (HSV-1) infections remain an important cause of corneal disease which may result in a loss of vision. Meliacine (MA), an antiviral activity present in crude leaf extracts of Melia azedarach L. that inhibits HSV-1 multiplication in vitro, was studied in a murine herpetic stromal keratitis experimental model. Adult Balb/c mice were inoculated with HSV-1 at their corneas after abrasion. MA was administered topically three times a day for 3 consecutive days, beginning at 24 and 96 hr after infection. Infected animals treated or not with MA were monitored for the development of ocular disease by a binocular microscope for 16 days. MA significantly reduced the incidence and the severity of blepharitis, neovascularization and stromal keratitis with respect to untreated infected mice, regardless the schedule of treatment assayed. Histological examination of corneas from MA-treated animals revealed no tissue damage, whereas corneal samples from untreated infected mice showed inflammation, vascularization and necrosis. In uninfected mice treated with MA, we found no evidence of corneal damage and histopathological studies showed no changes in the corneas of these mice. Treatment with MA at 24 hours post-infection (h.p.i.) reduced viral multiplication in the eye by 1-1.5 orders of magnitude. Studies on latency revealed that MA sligthly affected the establishment of a latent infection. Thus, MA proved to exert an antiviral action on the development of herpetic stromal keratitis when supplied by post-treatment. Unexpectedly, treatment with MA after 96 h.p.i prevented ocular disease, suggesting an in vivo immunomodulating activity of MA. © 2002 Elsevier Science Ltd. Fil:Paula Pifarré, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Coto, C.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Alché, L.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2002 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00144835_v75_n3_p327_PaulaPifarre http://hdl.handle.net/20.500.12110/paper_00144835_v75_n3_p327_PaulaPifarre
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Herpes simplex virus
In vivo
Latency
Melia azedarach L.
Murine model
Plant antiviral
Stromal keratitis
Melia azedarach extract
meliacine
plant extract
unclassified drug
animal cell
animal experiment
animal model
animal tissue
antiviral activity
article
controlled study
disease severity
Herpes simplex virus 1
histopathology
immunomodulation
inoculation
keratitis
microscopy
mouse
necrosis
nonhuman
priority journal
vascularization
spellingShingle Herpes simplex virus
In vivo
Latency
Melia azedarach L.
Murine model
Plant antiviral
Stromal keratitis
Melia azedarach extract
meliacine
plant extract
unclassified drug
animal cell
animal experiment
animal model
animal tissue
antiviral activity
article
controlled study
disease severity
Herpes simplex virus 1
histopathology
immunomodulation
inoculation
keratitis
microscopy
mouse
necrosis
nonhuman
priority journal
vascularization
Pifarré, María Paula
Coto, Celia Esther
Alche, Laura Edith
Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
topic_facet Herpes simplex virus
In vivo
Latency
Melia azedarach L.
Murine model
Plant antiviral
Stromal keratitis
Melia azedarach extract
meliacine
plant extract
unclassified drug
animal cell
animal experiment
animal model
animal tissue
antiviral activity
article
controlled study
disease severity
Herpes simplex virus 1
histopathology
immunomodulation
inoculation
keratitis
microscopy
mouse
necrosis
nonhuman
priority journal
vascularization
description Ocular herpes simplex virus type-1 (HSV-1) infections remain an important cause of corneal disease which may result in a loss of vision. Meliacine (MA), an antiviral activity present in crude leaf extracts of Melia azedarach L. that inhibits HSV-1 multiplication in vitro, was studied in a murine herpetic stromal keratitis experimental model. Adult Balb/c mice were inoculated with HSV-1 at their corneas after abrasion. MA was administered topically three times a day for 3 consecutive days, beginning at 24 and 96 hr after infection. Infected animals treated or not with MA were monitored for the development of ocular disease by a binocular microscope for 16 days. MA significantly reduced the incidence and the severity of blepharitis, neovascularization and stromal keratitis with respect to untreated infected mice, regardless the schedule of treatment assayed. Histological examination of corneas from MA-treated animals revealed no tissue damage, whereas corneal samples from untreated infected mice showed inflammation, vascularization and necrosis. In uninfected mice treated with MA, we found no evidence of corneal damage and histopathological studies showed no changes in the corneas of these mice. Treatment with MA at 24 hours post-infection (h.p.i.) reduced viral multiplication in the eye by 1-1.5 orders of magnitude. Studies on latency revealed that MA sligthly affected the establishment of a latent infection. Thus, MA proved to exert an antiviral action on the development of herpetic stromal keratitis when supplied by post-treatment. Unexpectedly, treatment with MA after 96 h.p.i prevented ocular disease, suggesting an in vivo immunomodulating activity of MA. © 2002 Elsevier Science Ltd.
author Pifarré, María Paula
Coto, Celia Esther
Alche, Laura Edith
author_facet Pifarré, María Paula
Coto, Celia Esther
Alche, Laura Edith
author_sort Pifarré, María Paula
title Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
title_short Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
title_full Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
title_fullStr Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
title_full_unstemmed Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice
title_sort therapeutic action of meliacine, a plant-derived antiviral, on hsv-induced ocular disease in mice
publishDate 2002
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00144835_v75_n3_p327_PaulaPifarre
http://hdl.handle.net/20.500.12110/paper_00144835_v75_n3_p327_PaulaPifarre
work_keys_str_mv AT pifarremariapaula therapeuticactionofmeliacineaplantderivedantiviralonhsvinducedoculardiseaseinmice
AT cotoceliaesther therapeuticactionofmeliacineaplantderivedantiviralonhsvinducedoculardiseaseinmice
AT alchelauraedith therapeuticactionofmeliacineaplantderivedantiviralonhsvinducedoculardiseaseinmice
_version_ 1768545078874210304